EUVIMEDEUVIMED entdecken
Crossref

Electroacupuncture at Baliao Points Alleviates Ulcerative Colitis via α7nAChR-Mediated Macrophage Polarization and Gut Microbiota Modulation

Xue Liu, Jiang-Bo Gao, Wen-Xuan Li, Chen-Yi Xu, Zhi-Yuan Zhang, Xu Yang, Min Ni iD

Inflammatory Bowel Diseases · 2026

DOI: 10.1093/ibd/izaf321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von Xue Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Electroacupuncture, alpha7 Nicotinic Acetylcholine Receptor, Colitis, Ulcerative, Macrophages. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Jiangsu Provincial Key Research and Development Program, Nanjing Health Science and Technology Development Foundation, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic inflammatory disorder characterized by a significant unmet clinical need for more effective and tolerable therapies. This study explores the therapeutic potential and underlying mechanisms of electroacupuncture (EA) at the Baliao acupoints in a dextran sulfate sodium (DSS)-induced UC rat model. EA treatment significantly alleviated colitis symptoms, restored colon length, and enhanced gut barrier integrity by upregulating tight junction proteins (ZO-1/occludin). Mechanistically, EA activated cholinergic neurons in the dorsal root ganglion (DRG), increased the prevalence of α7nAChR (alpha 7 nicotinic acetylcholine receptor)-positive M2 macrophages in the colon, and elevated local acetylcholine levels. These effects were abolished by the α7nAChR antagonist methyllycaconitine (MLA), confirming the critical role of α7nAChR-mediated cholinergic signaling. Additionally, EA modulated gut microbiota composition, promoting beneficial bacteria (eg Lactobacillus) and suppressing pathogenic species. Heart rate variability analysis indicated enhanced vagal activity post-EA. Collectively, these findings demonstrate that EA at the Baliao acupoints alleviates experimental UC via α7nAChR-dependent facilitation of M2 macrophage polarization and restoration of a healthy gut microbiota, highlighting a promising neuromodulation-based approach for UC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electroacupuncturealpha7 Nicotinic Acetylcholine ReceptorColitis, UlcerativeMacrophagesAcupuncture PointsGastrointestinal MicrobiomeAnimalsRatsMaleRats, Sprague-DawleyDisease Models, AnimalDextran SulfateColonMacrophage Activation

Stichwörter der Autor:innen

Baliao acupointM2 macrophage polarizationUlcerative colitisα7nAChR

Substanzen

alpha7 Nicotinic Acetylcholine ReceptorDextran Sulfate

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China.
  • Nanjing Hospital of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China.

ORCID-Profile: Min Ni

Förderung

  • Jiangsu Provincial Key Research and Development Program
  • Nanjing Health Science and Technology Development Foundation
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Liu, X., Gao, J. B., Li, W. X., Xu, C. Y., Zhang, Z. Y., Yang, X., & Ni, M. (2026). Electroacupuncture at Baliao Points Alleviates Ulcerative Colitis via α7nAChR-Mediated Macrophage Polarization and Gut Microbiota Modulation. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf321

Vancouver

Liu X, Gao JB, Li WX, Xu CY, Zhang ZY, Yang X, et al. Electroacupuncture at Baliao Points Alleviates Ulcerative Colitis via α7nAChR-Mediated Macrophage Polarization and Gut Microbiota Modulation. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izaf321

BibTeX
@article{Liu2026,
  author = {Liu, Xue and Gao, Jiang-Bo and Li, Wen-Xuan and Xu, Chen-Yi and Zhang, Zhi-Yuan and Yang, Xu and Ni, Min},
  title = {Electroacupuncture at Baliao Points Alleviates Ulcerative Colitis via α7nAChR-Mediated Macrophage Polarization and Gut Microbiota Modulation},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  doi = {10.1093/ibd/izaf321}
}
Kostenlos starten →